2023
DOI: 10.1016/j.cpcardiol.2021.101047
|View full text |Cite
|
Sign up to set email alerts
|

Representation of Chronic Kidney Disease in Randomized Controlled Trials Among Patients With Heart failure With Reduced Ejection Fraction: A Systematic Review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Specifically, we found untreated patients were significantly older than those with nephrologist consultation. Kidney failure in older people is usually associated with other comorbidities such as dementia, cognitive impairment [25,26], chronic heart failure, cardiovascular disease [27,28], diabetes, and hypertension [1,2,29], which dominate the clinical picture in ageing people. CKD is an indolent disease, which can limit patients' awareness [30][31][32] and, likely, general practitioners' diagnoses.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, we found untreated patients were significantly older than those with nephrologist consultation. Kidney failure in older people is usually associated with other comorbidities such as dementia, cognitive impairment [25,26], chronic heart failure, cardiovascular disease [27,28], diabetes, and hypertension [1,2,29], which dominate the clinical picture in ageing people. CKD is an indolent disease, which can limit patients' awareness [30][31][32] and, likely, general practitioners' diagnoses.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, from a patient‐ and outcome‐centered perspective, it is important to design studies where both HF and kidney end points are prespecified 44 , 45 ; this will allow cardiologists and nephrologists to collaborate to close gaps in the care of patients with HF and CKD. 45 , 46 …”
Section: Discussionmentioning
confidence: 99%
“…In 2004, Chertow et al (4) described the phenomenon of “renalism,” referring to the systematic exclusion of patients with CKD from cardiovascular trials of medical therapies and procedures due to a misconception of futility and/or harm. For example, in a systematic review of 706 RCTs for therapies in heart failure with reduced ejection fraction between 2010 and 2020, over a third of the trials had no information reported on kidney function (5). The number of trials that included patients with CKD was inversely related to eGFR, and patients on maintenance dialysis and kidney transplant recipients were included in <60 trials.…”
Section: Structural Inequitiesmentioning
confidence: 99%